Associate Director
Ironwood Pharmaceuticals
Associate Director
Ironwood Pharmaceuticals
Develops and commercializes GI therapeutics
Ironwood Pharmaceuticals is a leading global gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation or chronic idiopathic constipation. Ironwood is also advancing apraglutide, a next-generation, long-acting synthetic GLP-2 analog being developed for rare gastrointestinal diseases, including short bowel syndrome with intestinal failure. Building upon our history of GI innovation, we keep patients at the heart of our R&D and commercialization efforts to reduce the burden of GI diseases and address significant unmet needs.
Founded in 1998, Ironwood Pharmaceuticals is headquartered in Boston, Massachusetts, and has operations in Basel, Switzerland
Purpose/Summary:
The Associate Director, Biostatistics, is responsible for providing strategic, methodological, and operational statistical leadership to create value at Ironwood. The role partners closely with cross-functional teams to shape clinical development strategies and contributes to the design, analysis, interpretation, and communication of clinical data through development plans, study protocols, statistical analysis plans, clinical study reports, regulatory submissions, publications, and business development activities. The Associate Director ensures scientific rigor, data-driven decision-making, and alignment with overall product development objectives. The position is a hybrid position located onsite at our office in Basel, Switzerland.
Additional responsibilities include maintaining expertise in applicable regulatory guidance and industry best practices and promoting compliance through SOP development and training; leading the evaluation and implementation of innovative statistical methodologies to support drug development; and overseeing external vendors and CRO to ensure high quality, timely and compliant deliverables.
Essential Functions:
Requirements:
Develops and commercializes GI therapeutics
Ironwood develops and commercializes medicines for gastrointestinal diseases, with a focus on irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). Its therapies aim to alleviate GI symptoms and improve GI function through medicines developed via research and development and supported by strategic partnerships. The company differentiates itself through deep GI biology expertise and collaborations that help bring differentiated products to patients in a competitive biopharma market. Its goal is to deliver effective GI medicines that provide value to patients, healthcare providers, and shareholders, enabling ongoing progress in GI disease therapies.
Explore more opportunities at Ironwood Pharmaceuticals